Cargando…
Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
Skin cutaneous melanoma (SKCM) attracts attention worldwide for its extremely high malignancy. A novel term cytolytic activity (CYT) has been introduced as a potential immunotherapy biomarker associated with counter-regulatory immune responses and enhanced prognosis in tumors. In this study, we extr...
Autores principales: | Zhang, Haoxue, Liu, Yuyao, Hu, Delin, Liu, Shengxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957259/ https://www.ncbi.nlm.nih.gov/pubmed/35345444 http://dx.doi.org/10.3389/fonc.2022.844666 |
Ejemplares similares
-
Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
por: Nurzat, Yeltai, et al.
Publicado: (2021) -
CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021) -
New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021) -
Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016) -
Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM
por: Liu, Yuyao, et al.
Publicado: (2023)